As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

"There’s people walking around that obviously do not have blonde hair – yet they do. I don’t think that’s weird either. It’s ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Bank of America upgrades Peloton to Buy, citing potential for revenue growth and operational improvements under new CEO ... blockbuster weight loss drug Zepbound, designed to treat obesity ...

Viking Therapeutics (VKTX) shares are taking a dive in Monday's session despite on rising manufacturing concerns and competition between pharmaceutical rivals in the GLP-1 weight-loss drug space.

Viking Therapeutics (VKTX) released new clinical trial data on Sunday ... Texas. Ozempic and prescription weight-loss drugs: How they work, what they cost, side effects, and everything to know ...

A doctor from Ecuador is accused of prescribing drugs illegally to customers in Easton, New York City and New Jersey. Mauricio Sarmiento is charged with introducing misbranded drugs into ...